The trial of Abu Agila Mohammad Kheir Al‑Marimi, the Libyan national charged with involvement in the 1988 Lockerbie bombing, has been delayed for a third time, only days before proceedings were set to commence. Jury selection, which had been slated to get under way in Washington, D.C. on Wednesday, will now begin in January of next year after the defence disclosed “newly discovered evidence” that emerged on Friday 21 August.
According to lawyers representing Al‑Marimi, the evidence was previously unknown to both the defence and prosecutors from the United States authorities. They told the court that “Constitutional and ethical obligations necessitate the defence to analyse this development.” The attorneys said they met with Al‑Marimi on Sunday and he agreed that a postponement should be requested.
Judge Dabney Friedrich accepted the request, noting the potential significance of the fresh material and acknowledging that she would have been reluctant to grant an eleventh‑hour adjournment after months of speculation and extensive pre‑trial litigation. For the victims’ families and for Al‑Marimi himself, the latest delay means a verdict may not be reached until the following spring.
The postponement adds another chapter to a case that has endured countless twists over nearly four decades. Pan Am Flight 103, en route from Heathrow to New York, suffered an explosive device in its forward hold at 31,000 feet on 21 December 1988, disintegrating the aircraft. All 259 passengers and crew aboard were killed, and a further 11 people lost their lives in Lockerbie when wreckage struck their homes. Among the dead, 190 were American and 43 were British.
Al‑Marimi has been in U.S. custody since 2022 and was originally scheduled to stand trial in May 2025, a date set after a joint prosecution‑defence petition cited the case’s complexity and his health. The trial had previously been pencilled for April this year but was postponed again when the defence asked for additional preparation time.
The Lockerbie bombing has been the focus of a joint Scottish‑U.S. investigation since December 1988. Prosecutors from the Crown Office and detectives from Police Scotland were expected to travel to Washington to attend the proceedings, with Scottish witnesses anticipated to be among the first to testify. Laura Buchan, head of the Lockerbie probe team at the Crown Office and Procurator Fiscal Service, said: “I recognise that this adjournment will be disappointing for the families and for those who have followed this case over many years.” She added: “As the matter remains before the court, it would not be appropriate to comment on the reasons for the adjournment. Although these proceedings are being led by the United States authorities, Scottish prosecutors and police officers remain fully committed to supporting the pursuit of justice.”
Al‑Marimi, described as a grandfather in his seventies, is accused of carrying out the attack alongside two other Libyans who faced a Scottish tribunal in May 2000. Three judges heard the case at Camp Zeist, a former U.S. air base in the Netherlands. After eight months they concluded the bombing was an act of state‑sponsored terrorism conducted by members of the Libyan intelligence service. The panel convicted Abdulbasset Al‑Megrahi of murder and sentenced him to life imprisonment. Megrahi died of cancer in 2012 after being released on compassionate grounds by the Scottish government. The Scottish Criminal Cases Review Commission twice referred his conviction to an appeal tribunal, but the verdict was upheld.
The second Libyan, Al Amin Khalifah Fhimah, was acquitted and returned to Tripoli to a hero’s welcome. U.S. authorities state that Al‑Marimi admitted to participating in the bombing with Megrahi and Fhimah during questioning in a Libyan detention facility in 2012. That alleged confession was handed to Scottish investigators in 2017 and now forms a central part of the prosecution’s case. Al‑Marimi maintains the confession is false and was obtained under duress, but Justice Friedrich ruled it may be admitted as evidence at trial.